StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report released on Tuesday morning. The firm issued a sell rating on the stock.

Streamline Health Solutions Price Performance

Shares of STRM stock opened at $2.55 on Tuesday. Streamline Health Solutions has a 12 month low of $1.82 and a 12 month high of $9.75. The company has a current ratio of 0.46, a quick ratio of 0.46 and a debt-to-equity ratio of 0.72. The stock has a 50 day moving average of $2.73 and a two-hundred day moving average of $3.14. The company has a market capitalization of $10.90 million, a P/E ratio of -1.06 and a beta of 1.78.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Thursday, May 1st. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.10). Streamline Health Solutions had a negative return on equity of 56.96% and a negative net margin of 50.51%. The company had revenue of $4.70 million during the quarter, compared to analyst estimates of $4.70 million.

Hedge Funds Weigh In On Streamline Health Solutions

An institutional investor recently raised its position in Streamline Health Solutions stock. Nicholas Hoffman & Company LLC. raised its holdings in Streamline Health Solutions, Inc. (NASDAQ:STRM) by 8.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 52,299 shares of the company’s stock after purchasing an additional 4,166 shares during the quarter. Nicholas Hoffman & Company LLC. owned approximately 1.22% of Streamline Health Solutions worth $146,000 as of its most recent SEC filing. 31.74% of the stock is currently owned by institutional investors and hedge funds.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.